These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3582236)

  • 1. [Changes in the proliferative activity of cells from lymphoid organs of tumor-bearing mice after immunization with antitumoral vaccines].
    Zatula DG; Bikhunov VL; Iudin VM
    Eksp Onkol; 1987; 9(2):33-6. PubMed ID: 3582236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes of lymphoid cell cytotoxicity, shown in vitro, of mice bearing a syngeneic tumor after injection of killed tumor cells].
    Lafontaine N; Firket H
    C R Seances Soc Biol Fil; 1975; 169(2):456-8. PubMed ID: 126787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological reconstitution of nude mice transplanted with human malignant tumours.
    Jacobsen GK; Povlsen CO; Rygaard J
    Tokai J Exp Clin Med; 1983 Dec; 8(5-6):513-27. PubMed ID: 6681344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for endogenous IL-12 in tumor immunity: IL-12 is required for the acquisition of tumor-migratory capacity by T cells and the development of T cell-accepting capacity in tumor masses.
    Uekusa Y; Gao P; Yamaguchi N; Tomura M; Mukai T; Nakajima C; Iwasaki M; Takeuchi N; Tsujimura T; Nakazawa M; Fujiwara H; Hamaoka T
    J Leukoc Biol; 2002 Nov; 72(5):864-73. PubMed ID: 12429708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modulating effect of immunotherapy with modified tumor cells in transplantable lymphoma].
    Bratus' GG; Darchuk GF; Komissarenko VG; Nastenko EP
    Eksp Onkol; 1987; 9(2):36-40. PubMed ID: 3582237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine therapy of established tumors in the absence of autoimmunity.
    Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
    Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the host lymphocyte subsets during chemical carcinogenesis.
    Brodt P; Lala PK
    Cancer Res; 1983 Sep; 43(9):4315-22. PubMed ID: 6871866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement by cyclophosphamide of experimental pulmonary metastases formation of Lewis lung carcinoma. II. Reduction of the cyclophosphamide effect by repopulation with cells from lymphoid organs.
    Strzadała L; Rak J; Kuśnierczyk H
    Arch Immunol Ther Exp (Warsz); 1985; 33(6):831-6. PubMed ID: 3914253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinational immunotherapy for established tumors with engineered tumor vaccines and adenovirus-mediated gene transfer.
    Xiang J; Chen Y; Moyana T
    Cancer Gene Ther; 2000 Jul; 7(7):1023-33. PubMed ID: 10917205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of lymphocyte subpopulations in primary and secondary lymphoid organs of mice by a transplanted granulocytosis-inducing mammary carcinoma.
    Lee MY; Rosse C
    Cancer Res; 1982 Apr; 42(4):1255-60. PubMed ID: 7060002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of the cellular inoculation dose in the development of the inhibitory effect of transplantable tumors on metastasis].
    Arkhipov SA; Iunker VM; Gruntenko EV
    Vopr Onkol; 1985; 31(3):77-83. PubMed ID: 3992963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic melanoma vaccine expressing alphaGal epitopes induces antitumor immunity to autologous antigens in mice without signs of toxicity.
    Rossi GR; Mautino MR; Awwad DZ; Husske K; Lejukole H; Koenigsfeld M; Ramsey WJ; Vahanian N; Link CJ
    J Immunother; 2008; 31(6):545-54. PubMed ID: 18528300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgEs targeted on tumor cells: therapeutic activity and potential in the design of tumor vaccines.
    Reali E; Greiner JW; Corti A; Gould HJ; Bottazzoli F; Paganelli G; Schlom J; Siccardi AG
    Cancer Res; 2001 Jul; 61(14):5517-22. PubMed ID: 11454701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity.
    U'Ren L; Kedl R; Dow S
    Cancer Gene Ther; 2006 Nov; 13(11):1033-44. PubMed ID: 16841080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of two distinct subpopulations of suppressor cells in rats bearing chemically induced tumors.
    Iguchi S; Ishii Y; Yamaoka H; Sato N; Kikuchi K
    Neoplasma; 1981; 28(1):51-8. PubMed ID: 6456424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surmounting tumor-induced immune suppression by frequent vaccination or immunization in the absence of B cells.
    Oizumi S; Deyev V; Yamazaki K; Schreiber T; Strbo N; Rosenblatt J; Podack ER
    J Immunother; 2008 May; 31(4):394-401. PubMed ID: 18391756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitumor resistance in immunizing animals with normal syngeneic tissues].
    Fel' VIa; Malygin AM; Liepa BL; Ivanov VA
    Vopr Onkol; 1974; 20(2):40-5. PubMed ID: 4373910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.